T-Mobile USA, Inc. Enters into a Strategic Multi-Year Agreement with Amdocs to Support Its Customer Experience and Operational Excellence Journey
Rhea-AI Summary
Amdocs (NASDAQ:DOX) announced a new multi-year strategic agreement with T-Mobile USA on February 3, 2026, extending their long-term collaboration to support T-Mobile's growth and operational excellence.
The deal covers managed services, software development, GenAI implementation where applicable, and integration work tied to UScellular systems.
Positive
- None.
Negative
- None.
Market Reaction
Following this news, DOX has gained 4.82%, reflecting a moderate positive market reaction. Our momentum scanner has triggered 12 alerts so far, indicating notable trading interest and price volatility. The stock is currently trading at $77.59. This price movement has added approximately $367M to the company's valuation. Trading volume is very high at 3.4x the average, suggesting strong buying interest.
Data tracked by StockTitan Argus (15 min delayed). Upgrade to Silver for real-time data.
Market Reality Check
Peers on Argus
DOX was down -1.13% while key software peers were mixed: KVYO +1.26%, DBX +0.83%, GTLB +1.23%, and WIX -3.36%. This points to a stock-specific move rather than a sector-wide trend.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 15 | Annual report filing | Neutral | +1.1% | Filed Form 20-F and made fiscal 2025 annual report available to investors. |
| Dec 09 | AI platform deal | Positive | +0.2% | e& UAE selected Amdocs' generative AI platform to enhance telco operations. |
| Nov 11 | Product launch | Positive | -1.8% | Smart launched Amdocs connectX SaaS platform and KiQ app for Gen Z engagement. |
| Nov 11 | Strategic agreement | Positive | -1.8% | Multi-year Telia Finland deal to build next-generation digital BSS platform. |
| Nov 11 | OSS modernization deal | Positive | -1.8% | Vivo signed multi-year agreement to modernize OSS with cloud-native orchestration. |
Recent positive partnership and contract announcements have sometimes seen negative next-day moves, while regulatory and AI-related updates tended to align modestly with the news tone.
Over the last few months, Amdocs has reported several customer and regulatory milestones. It filed its 2025 Form 20-F and related annual report materials, and furnished quarterly results via Form 6-K. Commercially, it announced GenAI and digital experience initiatives with e& UAE, PLDT’s Smart, Telia Finland, and Vivo, often via multi-year modernization or platform agreements. Price reactions were modestly positive for the AI-focused e& UAE update and the annual report, but negative following multiple November 2025 deal announcements, providing context for today’s T-Mobile agreement.
Market Pulse Summary
This announcement extends Amdocs’ long-standing collaboration with T-Mobile USA, Inc. through a new multi-year agreement covering managed services, software development, GenAI implementation, and integration support. It reinforces Amdocs’ focus on large telecom customers and operational transformation projects. In context of prior multi-year deals and GenAI initiatives, investors may watch for disclosures on deal scope in future filings, revenue concentration with major carriers, and execution progress on complex integration programs.
Key Terms
genai technical
AI-generated analysis. Not financial advice.
The new agreement extends the long-term relationship and includes managed services, software development, AI innovation, and UScellular integration
JERSEY CITY, NJ / ACCESS Newswire / February 3, 2026 / Amdocs (NASDAQ:DOX), a leading provider of software and services to communications and media companies, today announced the extension of its long-standing strategic collaboration with T-Mobile USA, Inc. through a new multi-year agreement supporting T-Mobile's continued growth and operational excellence.
Under the new agreement, T-Mobile and Amdocs will collaborate to support T-Mobile's growth strategy and business objectives. Amdocs will continue to support T-Mobile's consumer and business domains, including implementation of GenAI technology where applicable. As part of this agreement, Amdocs will be leveraged to support integration activities related to common systems.
"Amdocs is proud to support T-Mobile USA, Inc. providing robust solutions and expertise to enable agility, efficiency, and growth," said Anthony Goonetilleke, Group President of Technology and Head of Strategy at Amdocs. "We are excited to deepen our collaboration as T-Mobile USA, Inc. continues to transform its operations and customer experience. Together, we're advancing the future of connectivity and customer engagement, setting new standards in the industry."
Supporting Resources
Keep up with Amdocs news by visiting the company's website
About T-Mobile USA, Inc.
T-Mobile US, Inc. (NASDAQ: TMUS) is America's supercharged Un-carrier, delivering an advanced 4G LTE and transformative nationwide 5G network that offers reliable connectivity for all. T-Mobile's customers benefit from its unmatched combination of value and quality, unwavering obsession with offering the best possible service experience, and undisputable drive for disruption that creates competition and innovation in wireless and beyond. For more information, visit www.t-mobile.com
About Amdocs
Amdocs helps the world's leading communications and media companies deliver exceptional customer experiences through reliable, efficient, and secure operations at scale. We provide software products and services that embed intelligence into how work runs across business, IT, and network domains - delivering measurable outcomes in customer experience, network performance, cloud modernization, and revenue growth. With our talented people, and more than 40 years of experience running mission-critical systems around the globe, Amdocs runs billions of transactions daily. Our technology is relied on every day, connecting people worldwide and advancing a more inclusive, connected world. Together, we help those who shape the future to make it amazing. Amdocs is listed on the NASDAQ Global Select Market (NASDAQ: DOX) and reported revenue of
Amdocs' Forward-Looking Statement
This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs' growth and business results in future quarters and years. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general macroeconomic conditions, prevailing level of macroeconomic, business and operational uncertainty, including as a result of geopolitical events or other regional events or pandemics, changes to trade policies including tariffs and trade restrictions, as well as the current inflationary environment, and the effects of these conditions on the Company's customers' businesses and levels of business activity, including the effect of the current economic uncertainty and industry pressure on the spending decisions of the Company's customers. Amdocs' ability to grow in the business markets that it serves, Amdocs' ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company's products and services obsolete, security incidents, including breaches and cyberattacks to our systems and networks and those of our partners or customers, potential loss of a major customer, our ability to develop long-term relationships with our customers, our ability to successfully and effectively implement artificial intelligence and Generative AI in the Company's offerings and operations, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, Amdocs specifically disclaims any obligation to do so. These and other risks are discussed at greater length in Amdocs' filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2025, filed on December 15, 2025.
Media Contacts
Mario Hajiloizi
Amdocs Public Relations
E-mail: mario.hajiloizi@amdocs.com
SOURCE: Amdocs Management Limited
View the original press release on ACCESS Newswire